This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Diagnosis

Authoring team

In patients who are suspected of having endometrial carcinoma, clinicians should obtain:

  • a detailed account of the presenting symptoms
  • complete drug history e.g. - HRT, oral contraceptive pill, tamoxifen
  • a gynaecological history to find out about early menarche/late menopause, known endometrial hyperplasia, parity
  • medical and surgical history - obesity, treatment for breast cancer, diabetes mellitus, hypothyroidism, hypertension, and Lynch-type syndrome (1)

General practitioners in the UK should refer women with postmenopausal bleeding to a rapid access gynaecology clinic to be seen within two weeks.

The following patients should be referred to a gynaecologist to rule out other possible sources of vaginal bleeding

  • premenopausal patient older than 40 years who presents with a recent onset abnormal bleeding pattern
  • a premenopausal patient of any age with an abnormal bleeding pattern and risk factors for endometrial cancer

A definitive diagnosis is made histologically through a tissue sample obtained either by a Pipelle curette (as an outpatient procedure) or by hysteroscopy and dilatation and curettage under general anaesthesia.

Patients who are confirmed of having endometrial cancer should be referred to a specialised gynaecology oncological centre for further evaluation (1).

Reference:


Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.